US 7863262
Nitroxyl progenitors in the treatment of heart failure
granted A61KA61K31/13A61K31/16
Quick answer
US patent 7863262 (Nitroxyl progenitors in the treatment of heart failure) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/13, A61K31/16, A61K31/655, A61K33/00